1-15 of 19
R/R LBCL: A Practical Guide to CAR T Referral and Coordination
Project Oncology®R/R LBCL: A Practical Guide to CAR T Referral and Coordination
Loretta J. Nastoupil, MD
Manali Kamdar, MD
The First Approved All-Oral, Fixed Duration Treatment for CLL: Insights from the AMPLIFY Trial
Project Oncology®The First Approved All-Oral, Fixed Duration Treatment for CLL: Insights from the AMPLIFY Trial
Jennifer Caudle, DO, FACOFP
Nicole Lamanna, MD
Cerebral Organoid Model Transforms Glioblastoma Research
Medical Industry FeatureCerebral Organoid Model Transforms Glioblastoma Research
Howard Fine, M.D.
Treatment Decisions in mCSPC: A Review of Retrospective Real-World Evidence
Medical Industry FeatureTreatment Decisions in mCSPC: A Review of Retrospective Real-World Evidence
Jennifer Caudle, DO, FACOFP
Gregory McMahon, DO
Potential for Early Intervention in 1L HR+/HER2- Advanced Breast Cancer
Medical Industry FeaturePotential for Early Intervention in 1L HR+/HER2- Advanced Breast Cancer
Seth Wander, MD, PhD
BRCA and HRD Biomarker Testing in Advanced Ovarian Cancer: A KOL Panel Discussion
Medical Industry FeatureBRCA and HRD Biomarker Testing in Advanced Ovarian Cancer: A KOL Panel Discussion
Sharyn N. Lewin, MD, FACS, FACOG
Dana Chase, MD
- advertisement
Ocular Management in PROC: Insights on Collaborative Care Across Practice Settings
Project Oncology®Ocular Management in PROC: Insights on Collaborative Care Across Practice Settings
Jennifer Caudle, DO, FACOFP
Ida Micaily, MD
Jeffrey Varanelli, OD
Identifying and Managing Adult Patients with Chronic Immune Thrombocytopenia
Medical Industry FeatureIdentifying and Managing Adult Patients with Chronic Immune Thrombocytopenia
Sandhya Panch, MD, MPH
ReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Medical Industry FeatureReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Sarah Sammons, MD
Advancing Care in ER+/HER2− ESR1m mBC: What EMERALD and Real-World Analyses Tell Us
Medical Industry FeatureAdvancing Care in ER+/HER2− ESR1m mBC: What EMERALD and Real-World Analyses Tell Us
Jennifer Caudle, DO, FACOFP
Seth Wander, MD, PhD
Expanding Treatment Options in PNH: Expert Approaches to Personalized Care
Medical Industry FeatureExpanding Treatment Options in PNH: Expert Approaches to Personalized Care
Caroline Piatek, MD
Bhumika Patel, MD
Long-Term PNH Management: Addressing Treatment Goals Beyond Symptom Control
Medical Industry FeatureLong-Term PNH Management: Addressing Treatment Goals Beyond Symptom Control
Arati Chand, MD
Bhumika Patel, MD
- advertisement
Understanding the Mechanism Behind a Treatment Approach in Indolent Systemic Mastocytosis (ISM)
Medical Industry FeatureUnderstanding the Mechanism Behind a Treatment Approach in Indolent Systemic Mastocytosis (ISM)
Rewiring Your Thinking in Paroxysmal Nocturnal Hemoglobinuria
Medical Industry FeatureRewiring Your Thinking in Paroxysmal Nocturnal Hemoglobinuria
Steve Stone, PA-C
George Yaghmour, MD
Personalizing PNH Care: Exploring the Role of Iptacopan in Clinical Practice
Medical Industry FeaturePersonalizing PNH Care: Exploring the Role of Iptacopan in Clinical Practice
Steve Stone, PA-C
Srinivasa Sanikommu, MD
